GRAIL, Inc. has secured $325.0 million in private placement financing to support its cancer detection mission, with lead investor Morgan Stanley. The funding will aid in commercial activities and working capital.
Amount Raised
$325 Million
Round Type
Post-IPO Equity
Menlo ParkBiotechnologyHealth CareMedicalMedical DeviceGeneticsHealth DiagnosticsresearchInvestors
Description
GRAIL, Inc. announced a securities purchase agreement for a private placement expected to yield approximately $325.0 million. The offering has participation from both new and existing institutional investors, led by Morgan Stanley. Proceeds will be used for commercial activities, reimbursement efforts, and general corporate purposes
Quick answer
Grail raised $325 Million in a Post-IPO Equity round, dated October 20, 2025. Investors: Goldman Sachs & Co. LLC, Braidwell LP, Deep Track Capital, Farallon Capital Management, Hims & Hers and Morgan Stanley. Grail is based in Menlo Park, California, United States.
- How much did Grail raise?
- Grail raised $325 Million in a Post-IPO Equity round on October 20, 2025.
- Who invested in Grail?
- Goldman Sachs & Co. LLC, Braidwell LP, Deep Track Capital, Farallon Capital Management, Hims & Hers and Morgan Stanley are named as investors in this round.
- What does Grail do?
- Grail is a healthcare company focused on the early detection of cancer through its innovative liquid biopsy technology.
- Where is Grail based and how big is it?
- Grail is based in Menlo Park, California, United States. Fundz records about 1,000 employees.
- Who are the decision-makers at Grail?
- Fundz holds 3 contacts at Grail, including the Head of US Employer Distribution Partnerships, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as Grail that raised within 45 days of this round, from Fundz verified event records.
- GE HealthCare Technologies raised $1.3B (Debt Financing) on December 2, 2025.
- ENDRA Life Sciences raised $14M on October 10, 2025.
- Kestra Medical Technologies raised $159M (Post-IPO Equity) on December 4, 2025.
- a2z Radiology AI raised $1.5M (Pre-Seed) on December 2, 2025.
- Healthplus.ai raised $2.7M (Seed) on November 29, 2025.
- Venstra Medical raised an undisclosed amount (Funding Round) on November 18, 2025.
Who to call at Grail, and when
A new round usually means Grail is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Grail raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Grail, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Grail. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Grail raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Grail raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.